GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Equity-to-Asset

Deinove (XPAR:ALDEI) Equity-to-Asset : -2.57 (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is Deinove Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Deinove's Total Stockholders Equity for the quarter that ended in Jun. 2022 was €-15.48 Mil. Deinove's Total Assets for the quarter that ended in Jun. 2022 was €6.01 Mil. Therefore, Deinove's Equity to Asset Ratio for the quarter that ended in Jun. 2022 was -2.57.

The historical rank and industry rank for Deinove's Equity-to-Asset or its related term are showing as below:

XPAR:ALDEI's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

Deinove Equity-to-Asset Historical Data

The historical data trend for Deinove's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Equity-to-Asset Chart

Deinove Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.09 -0.64 -1.07 -1.39

Deinove Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.90 -1.07 -1.15 -1.39 -2.57

Competitive Comparison of Deinove's Equity-to-Asset

For the Biotechnology subindustry, Deinove's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deinove's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Deinove's Equity-to-Asset falls into.



Deinove Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Deinove's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Equity to Asset (A: Dec. 2021 )=Total Stockholders Equity/Total Assets
=-13.031/9.377
=-1.39

Deinove's Equity to Asset Ratio for the quarter that ended in Jun. 2022 is calculated as

Equity to Asset (Q: Jun. 2022 )=Total Stockholders Equity/Total Assets
=-15.475/6.011
=-2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deinove  (XPAR:ALDEI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Deinove Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Deinove's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Deinove (XPAR:ALDEI) Business Description

Traded in Other Exchanges
N/A
Address
1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790
Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines